A study of the role of GATA4 polymorphism in cardiovascular metabolic disorders

Human Genomics

Volumn 7, Issue 1, 2013, Pages

  Muiya, Nzioka P ^a   Wakil, Salma M ^a   Tahir, Asma I ^a   Hagos, Samya ^a   Najai, Mohammed ^a   Gueco, Daisy ^a   Al Tassan, Nada ^a   Andres, Editha ^a   Mazher, Nejat ^a   Meyer, Brian F ^a   Dzimiri, Nduna ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Coronary artery disease; Dyslipidaemia; GATA4 gene polymorphism; Haplotypes; High density lipoprotein cholesterol; Hypercholesterolaemia; Hypertriglyceridaemia; Low density lipoprotein cholesterol

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRANSCRIPTION FACTOR GATA 4; TRIACYLGLYCEROL; GATA4 PROTEIN, HUMAN;

ADULT; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CHROMOSOME 8; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY HISTORY; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; HEART INFARCTION; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; CASE CONTROL STUDY; DNA SEQUENCE; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; HETEROZYGOTE; METABOLISM; MIDDLE AGED; PHENOTYPE; RISK FACTOR;

CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 8; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; GATA4 TRANSCRIPTION FACTOR; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HETEROZYGOTE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; METABOLIC DISEASES; MIDDLE AGED; MYOCARDIAL INFARCTION; OBESITY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEQUENCE ANALYSIS, DNA;

EID: 84901007684     PISSN: 14739542     EISSN: 14797364     Source Type: Journal    
DOI: 10.1186/1479-7364-7-25     Document Type: Article

References (39)

1. Narita N, Bielinska M, Wilson DB: Wild-type endoderm abrogates the ventral developmental defects associated with GATA-4 deficiency in the mouse. Dev Biol 1997, 189(2):270-274. (Pubitemid 27428368)
2. Fujikura J, Yamato E, Yonemura S, Hosoda K, Masui S, Nakao K, Miyazaki Ji J, Niwa H: Differentiation of embryonic stem cells is induced by GATA factors. Genes Dev 2002, 16(7):784-789. (Pubitemid 34280102)
3. Morrisey EE, Ip HS, Tang Z, Parmacek MS: GATA-4 activates transcription via two novel domains that are conserved within the GATA-4/5/6 subfamily. J Biol Chem 1997, 272(13):8515-8524. (Pubitemid 27147815)
4. Morrisey EE, Ip HS, Tang Z, Lu MM, Parmacek MS: GATA-5: a transcriptional activator expressed in a novel temporally and spatially-restricted pattern during embryonic development. Dev Biol 1997, 183(1):21-36. (Pubitemid 27157830)
5. Watt AJ, Battle MA, Li J, Duncan SA: GATA4 is essential for formation of the proepicardium and regulates cardiogenesis. Proc Natl Acad Sci USA 2004, 101(34):12573-12578. (Pubitemid 39122065)
6. Pikkarainen S, Tokola H, Kerkela R, Ruskoaho H: GATA transcription factors in the developing and adult heart. Cardiovasc Res 2004, 63(2):196-207. (Pubitemid 38900834)
7. Zeisberg EM, Ma Q, Juraszek AL, Moses K, Schwartz RJ, Izumo S, Pu WT: Morphogenesis of the right ventricle requires myocardial expression of Gata4. J Clin Invest 2005, 115(6):1522-1531. (Pubitemid 40814660)
8. Crispino JD, Lodish MB, Thurberg BL, Litovsky SH, Collins T, Molkentin JD, Orkin SH: Proper coronary vascular development and heart morphogenesis depend on interaction of GATA-4 with FOG cofactors. Genes Dev 2001, 15(7):839-844. (Pubitemid 32295065)
9. Reiter JF, Alexander J, Rodaway A, Yelon D, Patient R, Holder N, Stainier DY: Gata5 is required for the development of the heart and endoderm in zebrafish. Genes Dev 1999, 13(22):2983-2995.
10. Molkentin JD, Lin Q, Duncan SA, Olson EN: Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev 1997, 11(8):1061-1072. (Pubitemid 27199884)
11. Charron F, Nemer M: GATA transcription factors and cardiac development. Semin Cell Dev Biol 1999, 10(1):85-91. (Pubitemid 129505541)
12. Durocher D, Grepin C, Nemer M: Regulation of gene expression in the endocrine heart. Recent Prog Horm Res 1998, 53:7-23. Discussion 22-23.
13. Shiojima I, Komuro I, Oka T, Hiroi Y, Mizuno T, Takimoto E, Monzen K, Aikawa R, Akazawa H, Yamazaki T, Kudoh S, Yazaki Y: Context-dependent transcriptional cooperation mediated by cardiac transcription factors Csx/Nkx-2.5 and GATA-4. J Biol Chem 1999, 274(12):8231-8239.
14. Fox AH, Kowalski K, King GF, Mackay JP, Crossley M: Key residues characteristic of GATA N-fingers are recognized by FOG. J Biol Chem 1998, 273(50):33595-33603. (Pubitemid 29005746)
15. Molkentin JD: The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression. J Biol Chem 2000, 275(50):38949-38952. (Pubitemid 32058903)
16. GNF Normal Tissue Atlas. GATA4 (GATA binding protein 4). 2013. http://biogps.org/#goto=genereport&id=2626.
17. Heineke J, Auger-Messier M, Xu J, Oka T, Sargent MA, York A, Klevitsky R, Vaikunth S, Duncan SA, Aronow BJ, Robbins J, Crombleholme TM, Molkentin JD: CardiomyocyteGATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart. J Clin Invest 2007, 117(11):3198-3210. (Pubitemid 350096978)
18. Oka T, Maillet M, Watt AJ, Schwartz RJ, Aronow BJ, Duncan SA, Molkentin JD: Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ Res 2006, 98(6):837-845.
19. Rivera-Feliciano J, Lee KH, Kong SW, Rajagopal S, Ma Q, Springer Z, Izumo S, Tabin CJ, Pu WT: Development of heart valves requires Gata4 expression in endothelial-derived cells. Development 2006, 133(18):3607-3618. (Pubitemid 44614283)
20. Hatcher CJ, Diman NY, McDermott DA, Basson CT: Transcription factor cascades in congenital heart malformation. Trends Mol Med 2003, 9(12):512-515. (Pubitemid 38017187)
21. Hirayama-Yamada K, Kamisago M, Akimoto K, Aotsuka H, Nakamura Y, Tomita H, Furutani M, Imamura S, Takao A, Nakazawa M, Matsuoka R: Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect. Am J Med Genet A 2005, 135(1):47-52. (Pubitemid 40627663)
22. Sarkozy A, Conti E, Neri C, D'Agostino R, Digilio MC, Esposito G, Toscano A, Marino B, Pizzuti A, Dallapiccola B: Spectrum of atrial septal defects associated with mutations of NKX2.5 and GATA4 transcription factors. J Med Genet 2005, 42(2):e16.
23. Okubo A, Miyoshi O, Baba K, Takagi M, Tsukamoto K, Kinoshita A, Yoshiura K, Kishino T, Ohta T, Niikawa N, Matsumoto N: A novel GATA4 mutation completely segregated with atrial septal defect in a large Japanese family. J Med Genet 2004, 41(7):e97.
24. Maslen CL: Molecular genetics of atrioventricular septal defects. Curr Opin Cardiol 2004, 19(3):205-210. (Pubitemid 38657438)
25. Reamon-Buettner SM, Cho SH, Borlak J: Mutations in the 3′-untranslated region of GATA4 as molecular hotspots for congenital heart disease (CHD). BMC Med Genet 2007, 8:38.
26. Tomita-Mitchell A, Maslen CL, Morris CD, Garg V, Goldmuntz E: GATA4 sequence variants in patients with congenital heart disease. J Med Genet 2007, 44(12):779-783. (Pubitemid 350275051)
27. Saffirio C, Marino B, Digilio MC: GATA4 as candidate gene for pericardial defects. Ann Thorac Surg 2007, 84(6):2137. (Pubitemid 350122440)
28. Rajagopal SK, Ma Q, Obler D, Shen J, Manichaikul A, Tomita-Mitchell A, Boardman K, Briggs C, Garg V, Srivastava D, Goldmuntz E, Broman KW, Benson DW, Smoot LB, Pu WT: Spectrum of heart disease associated with murine and human GATA4 mutation. J Mol Cell Cardiol 2007, 43(6):677-685. (Pubitemid 350166377)
29. Azakie A, Fineman JR, He Y: Myocardial transcription factors are modulated during pathologic cardiac hypertrophy in vivo. J Thorac Cardiovasc Surg 2006, 132(6):1262-1271.
30. Reamon-Buettner SM, Borlak J: GATA4 zinc finger mutations as a molecular rationale for septation defects of the human heart. J Med Genet 2005, 42(5):e32.
31. American Heart Association: Arteriosclerosis, Thrombosis, and Vascular Biology Annual Conference 2007. Thromb Vasc Biol 2007, 27(6):e35-e137.
32. Dzimiri N, Al-Najai M, Elhawari S, Gueco D, Vigilla MG, Andres E, Muiya P, Mazher N, Alshahid M, Meyer BF: The interaction of AGT gene polymorphism with cardiovascular risk traits in atherosclerosis. Arterioscler Thromb Vasc Biol 2012, 32(5-MeetingAbstracts):A524.
33. WMA Declaration of Helsinki - ethical principles for medical research involving human subjects. [http://www.wma.net/en/30publications/10policies/b3/ index.html].
34. Alshahid M, Wakil SM, Al-Najai M, Muiya NP, Elhawari S, Gueco D, Andres E, Hagos S, Mazhar N, Meyer BF, Dzimiri N: New susceptibility locus for obesity and dyslipidaemia on chromosome 3q22.3. Hum Genomics 2013, 7:15.
35. Elhawari S, Al-Boudari O, Muiya P, Khalak H, Andres E, Al-Shahid M, Al-Dosari M, Meyer BF, Al-Mohanna F, Dzimiri N: A study of the role of the myocyte-specific enhancer factor-2A gene in coronary artery disease. Atherosclerosis 2010, 209(1):152-154.
36. Schaid DJ: Statistical genetics and genetic epidemiology. [http://mayoresearch.mayo.edu/mayo/research/schaid-lab/software.cfm].
37. The R Project for Statistical Computing. [http://www.r-project.org/].
38. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA: Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002, 70(2):425-434. (Pubitemid 34112296)
39. Lake SL, Lyon H, Tantisira K, Silverman EK, Weiss ST, Laird NM, Schaid DJ: Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered 2003, 55(1):56-65. (Pubitemid 36928747)